Lisman, T <br/><br/>
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis.  [electronic resource] 

 -  Gastroenterology  Jul 2001 
 - 131-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0016-5085 
<br/><br/><label>Standard No.: </label>10.1053/gast.2001.25481  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens--blood<br/>Antithrombins--metabolism<br/>Blood Coagulation--drug effects<br/>Carboxypeptidase B2<br/>Carboxypeptidases--deficiency<br/>Fibrin Fibrinogen Degradation Products--metabolism<br/>Fibrinolysis--drug effects<br/>Humans<br/>Liver Cirrhosis--blood<br/>Time Factors